| Literature DB >> 24745013 |
Marcin Zyczkowski1, Krzysztof Nowakowski1, Waclaw Kuczmik2, Tomasz Urbanek2, Zbiegniew Kaletka1, Piotr Bryniarski1, Bartosz Muskala1, Andrzej Paradysz1.
Abstract
INTRODUCTION: This study is a comparative evaluation of the TVT, TOT, and our own modification of TOT (mTOT) in the treatment of female stress urinary incontinence from a single center experience.Entities:
Mesh:
Year: 2014 PMID: 24745013 PMCID: PMC3976787 DOI: 10.1155/2014/347856
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Comparison of the study groups.
| Group I (TVT) | Group II (TOT) | Group III (mTOT) |
| |
|---|---|---|---|---|
| Number of patients | 142 (26,9%) | 129 (24,5%) | 256 (48,6%) | |
| Age | 55,2 ± 8,3 | 54,7 ± 7,8 | 55,9 ± 8,6 | 0,115 |
| Complications | 19 (13,4%) | 12 (9,3%) | 22 (8,6%) | 0,04 |
| Operation time (min) | 32,3 | 28,2 | 26,4 | 0,33 |
| Hospitalization time | 2,54 | 2,48 | 2,50 | 0,76 |
| Catheter maintenance | 1,84 | 1,58 | 1,52 | 0,04 |
Figure 1Polypropylene mesh used to prepare TOT tape.
Figure 2Close-up of polypropylene mesh shown in Figure 1.
Figure 3Tape prepared for the mTOT procedure with Stamey needle.
Cure rates in 1 month after surgery.
| Group I (TVT) | Group II (TOT) | Group III (mTOT) |
| |
|---|---|---|---|---|
| Cough test negative | 128 (90,1%) | 118 (91,5%) | 236 (92,2%) | 0,09 |
| Pad test negative | 133 (93,7%) | 122 (94,6%) | 241 (94,1%) | 0,88 |
| Satisfied with surgery | 135 (95,1%) | 123 (95,3%) | 244 (95,3%) | 0,91 |
Cure rates in 3 months after surgery.
| Group I (TVT) | Group II (TOT) | Group III (mTOT) |
| |
|---|---|---|---|---|
| Cough test negative | 129 (90,8%) | 120 (93,0%) | 238 (92,9%) | 0,07 |
| Pad test negative | 133 (93,7%) | 121 (93,8%) | 241 (94,1%) | 0,95 |
| Satisfied with surgery | 137 (96,4%) | 123 (95,3%) | 246 (96,1%) | 0,88 |
Cure rates in 6 months after surgery.
| Group I (TVT) | Group II (TOT) | Group III (mTOT) |
| |
|---|---|---|---|---|
| Cough test negative | 130 (91,5%) | 120 (93,0%) | 239 (93,3%) | 0,08 |
| Pad test negative | 134 (94,4%) | 120 (93,0%) | 243 (94,9%) | 0,12 |
| Satisfied with surgery | 137 (96,4%) | 124 (96,1%) | 247 (96,4%) | 0,98 |
Complications.
| Group I (TVT) | Group II (TOT) | Group III (mTOT) |
| |
|---|---|---|---|---|
| Bladder injury | 6 (4,2%) | 1 (0,7%) | 2 (0,7%) | 0,01 |
| De novo OAB | 5 (3,5%) | 6 (4,7%) | 11 (4,3%) | 0,15 |
| Postvoid residual | 7 (4,9%) | 3 (2,3%) | 7 (2,7%) | 0,09 |
| Tape extrusion | 1 (0,7%) | 2 (1,6%) | 2 (0,7%) | 0,22 |
Comparison between TVT and overall TOT in 6 months after surgery.
| TVT ( | Overall TOT ( |
| |
|---|---|---|---|
| Cough test negative | 130 (91,5%) | 359 (93,2%) | 0,07 |
| Pad test negative | 134 (94,4%) | 363 (94,3%) | 0,98 |
| Satisfied with surgery | 137 (96,4%) | 371 (96,4%) | 0,99 |
| Complications | 19 (13,4%) | 34 (8,8%) | 0,01 |
Comparison between TOT and TOT with our own modification (mTOT).
| TOT ( | mTOT ( |
| |
|---|---|---|---|
| Cough test negative | 120 (93,0%) | 239 (93,3%) | 0,09 |
| Pad test negative | 120 (93,0%) | 243 (94,9%) | 0,88 |
| Satisfied with surgery | 124 (96,1%) | 247 (96,4%) | 0,08 |
| Complications | 12 (9,3%) | 22 (8,6%) | 0,07 |